1. Home
  2. ATOS vs EVF Comparison

ATOS vs EVF Comparison

Compare ATOS & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$4.99

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Senior Income Trust

EVF

Eaton Vance Senior Income Trust

HOLD

Current Price

$4.96

Market Cap

95.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATOS
EVF
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
36.2M
95.9M
IPO Year
2010
1998

Fundamental Metrics

Financial Performance
Metric
ATOS
EVF
Price
$4.99
$4.96
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$31.67
N/A
AVG Volume (30 Days)
89.0K
90.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
16.67
N/A
EPS
N/A
N/A
Revenue
$1,758.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$4.77
52 Week High
$7.56
$5.93

Technical Indicators

Market Signals
Indicator
ATOS
EVF
Relative Strength Index (RSI) 66.34 24.06
Support Level $0.68 N/A
Resistance Level $5.12 $5.35
Average True Range (ATR) 0.35 0.05
MACD -0.06 -0.01
Stochastic Oscillator 72.46 0.00

Price Performance

Historical Comparison
ATOS
EVF

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

Share on Social Networks: